You deserve tomorrow.

Company History


  • Salisbury site acquired in 1983 by F H Faulding & Co Limited.
  • Development of delayed-release Doxycycline capsules (Doryx™).
  • Development of enteric coated aspirin (Astrix™).
  • WF Scammell Research Centre opened at Salisbury.


  • Development of taste-masking technology (Cleantaste™).
  • Development of sustained-release morphine (Kadian™ / Kapanol™).
  • Metrics founded as a contract testing company in Greenville, North Carolina.


  • Development of improved bioavailability technology (SUBA™).
  • Development of pellet-in-a-tablet technology (Doryx™).
  • Development of Lozanoc™ improved formulation of itraconazole.


  • Mayne Pharma acquires Metrics, Inc. - CDMO with niche generic product portfolio and pipeline.
  • Mayne Pharma acquires Libertas, Inc. - US based generics business.
  • Acquired Doryx™ brand and related assets in the US from Actavis.
  • Mayne Pharma launches Specialty Brands Sales Team to promote Doryx™ in the US.